Apptillion.

Public-company intelligence, source by source

Follow NWBO without piecing every update together.

The Enhanced email briefing on public NWBO and DCVax developments, with source links and clear labels for what is supported and what remains unverified.

Primary sources firstRumors stay labeledConfirm before delivery

Register for Enhanced.

Filings, trials, court updates, and meaningful community claims in one source-aware briefing.

Due to the high costs of API calls and AI token usage, the Free NWBO Monitor ended after the October 31, 2026 edition. New subscriptions are available through Enhanced for $7/month.

Enhanced arrives at 6:15 PM Eastern, Monday through Saturday. No Sunday edition.

Enhanced Monitor: $7/month

Filings, trial updates, litigation, and verified context, plus clearly labeled community signals.

Register for Enhanced

Create an account, verify your email, then complete secure Stripe checkout. Creating an account alone does not charge you. Cancel anytime.

Already registered? Log in to your Enhanced account.

Previous day's Enhanced edition

The previous day's Enhanced edition is not available.

Enhanced publishes Monday through Saturday, with no Sunday edition. Register above to receive new editions by email.

Built from an explicit source policy

Primary records can confirm a development. Community and discovery sources can identify leads that still require verification.

company

Northwest Biotherapeutics

Company announcements, filings, publications, and corporate updates from NWBio.

Open source
regulatory

SEC EDGAR

10-K, 10-Q, 8-K, registration, ownership, and other filings for CIK 0001072379.

Open source
government

ClinicalTrials.gov

Study registrations, status changes, sponsors, interventions, and posted results.

Open source
government

UK MHRA and GOV.UK

UK regulator guidance and public records relevant to medicines and marketing authorization.

Open source
government

CourtListener

Public docket metadata and available RECAP documents for NWBO-related litigation.

Open source
technology

USPTO Patent Center

Patent applications, grants, and prosecution records tied to relevant NWBO entities.

Open source
technology

WIPO PATENTSCOPE

International patent publication and application records for relevant entities and technologies.

Open source
community

Publicly indexed X coverage

Authorized read-only public-index discovery for NWBO and DCVax discussion; not proof of a material claim.

Open source
community

Stocktwits $NWBO

Public community discussion and market context, retained separately from verified company records.

Open source
community

r/NWBO

Public manual review of investor discussion and resurfaced claims.

Open source

Every item carries its status

Confirmed

Supported directly by a primary record or named counterparty.

Company Reported

A statement made by NWBio that may still need independent context.

Regulatory / Filing

An SEC filing, regulator action, docket, or other official record.

Credible Reporting

Independent reporting with identifiable sourcing and editorial accountability.

Clinical / Science

A trial, publication, conference, or scientific record with a clear NWBO connection.

Community Signal

Discussion worth checking, not evidence that a claim is true.

Unverified

A material claim that could not be confirmed from reliable sources.

Not Supported

Available evidence did not support the claim as stated.

Previously Reported

Accurate context that is resurfacing but is not a new development.

Correction

A transparent correction attached to the affected edition or claim.

This monitor organizes public information and authorized read-only community sources. It is not affiliated with Northwest Biotherapeutics and is not investment or medical advice.